Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli | Human immunodeficiency virus 2 |
Protein Variants | Comment | Organism |
---|---|---|
D25N | inactive mutant forms a dimer | Human immunodeficiency virus 2 |
DELTA96-99 | dimer interface mutations such as a deletion of the C-terminal residues 96-99 (PR21-95), drastically increase the Kd. Deletion mutant consists predominantly of folded monomers. Addition of 2fold excess active-site inhibitor does not promote dimerization | Human immunodeficiency virus 2 |
E37K | mutation significantly retards autoproteolytic cleavage during expression. Mutant shows a higher dimer dissociation constant, Kd, compared to wild-type. Km and kcat values for substrate Lys-Ala-Arg-Val-Nle-(4-nitrophenylalanine)-Glu-Ala-Nle comparable to wild-type | Human immunodeficiency virus 2 |
T26A | dimer interface mutations in the active site of PR2 drastically increase the Kd. T26A consists predominantly of folded monomers. Addition of 2fold excess active-site inhibitor promotes dimerization of mutant PR2T26A | Human immunodeficiency virus 2 |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
darunavir | - |
Human immunodeficiency virus 2 |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.071 | - |
Lys-Ala-Arg-Val-Nle-(4-nitrophenylalanine)-Glu-Ala-Nle | mutant E37K2, pH 5.0, 28°C | Human immunodeficiency virus 2 | |
0.072 | - |
Lys-Ala-Arg-Val-Nle-(4-nitrophenylalanine)-Glu-Ala-Nle | wild-type PR2, pH 5.0, 28°C | Human immunodeficiency virus 2 |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Human immunodeficiency virus 2 | enzyme undergoes autoproteolysis at pH 3 at the G35/I36 site | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human immunodeficiency virus 2 | - |
- |
- |
Storage Stability | Organism |
---|---|
4°C, phosphate buffer pH 6 and 50 mM NaCl, 72 h, no loss of activity | Human immunodeficiency virus 2 |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Lys-Ala-Arg-Val-Nle-(4-nitrophenylalanine)-Glu-Ala-Nle + H2O | - |
Human immunodeficiency virus 2 | ? | - |
? | |
additional information | enzyme undergoes autoproteolysis at pH 3 at the G35/I36 site | Human immunodeficiency virus 2 | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
HIV-2 protease | - |
Human immunodeficiency virus 2 |
PR2 | - |
Human immunodeficiency virus 2 |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
28 | - |
assay at | Human immunodeficiency virus 2 |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
additional information | - |
Tm: 60.5°C, binding of darunavir increases Tm by 14.8°C | Human immunodeficiency virus 2 |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
5.6 | - |
Lys-Ala-Arg-Val-Nle-(4-nitrophenylalanine)-Glu-Ala-Nle | mutant E37K2, pH 5.0, 28°C | Human immunodeficiency virus 2 | |
6.4 | - |
Lys-Ala-Arg-Val-Nle-(4-nitrophenylalanine)-Glu-Ala-Nle | wild-type PR2, pH 5.0, 28°C | Human immunodeficiency virus 2 |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
3 | - |
enzyme undergoes autoproteolysis at pH 3 at the G35/I36 site | Human immunodeficiency virus 2 |
5 | - |
assay at | Human immunodeficiency virus 2 |